Načítá se...

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients

Background: The clinical course of relapsing-remitting multiple sclerosis (RRMS) is highly heterogeneous and prognostic biomarkers at time of diagnosis are lacking. Objective: We investigated the predictive value of the plasma proteome at time of diagnosis in RRMS patients. Methods: The plasma prote...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Mol Neurosci
Hlavní autoři: Bridel, Claire, Eijlers, Anand J. C., van Wieringen, Wessel N., Koel-Simmelink, Marleen, Leurs, Cyra E., Schoonheim, Menno M., Killestein, Joep, Teunissen, Charlotte E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220078/
https://ncbi.nlm.nih.gov/pubmed/30429773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2018.00371
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!